Comera Life Sciences Holdings Receivables

Comera Life Sciences Holdings's receivables stands at $100K as of September 2023. That compares with $290K in the prior-year period — down 66.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Comera Life Sciences Holdings reported $100K in receivables versus $290K a year earlier — a 66.0% year-over-year decrease. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $290K in the prior-year period — down 66.0% year over year. Sustained growth in receivables can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Comera Life Sciences Holdings's receivables evolved across reporting periods, while the comparison chart places CMRA next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.